Literature DB >> 18239604

Are non-prescription medications needed for weight control?

George A Bray1.   

Abstract

At any one time large numbers of people are attempting to control their weight. Women are the principal consumers of weight-control programs. Their options, outside the prescription drug market and surgical treatment, include diets and diet books, exercise alone or with supervision in exercise facilities, dietary supplements, group programs, doctors, dietitians, psychologists, and other health-care professionals. Non-prescription products available to help people control their weight cover a wide range, including herbal dietary supplements, diet drinks and portion-controlled foods, meal replacements, and low-carbohydrate diets and foods. The introduction of orlistat as an over-the-counter (OTC) product will provide the only Food and Drug Administration (FDA)-approved product for weight loss currently in that category since phenylpropanolamine (PPA) was withdrawn by the FDA. The FDA approval process is considerably more expensive than allowing untested herbal supplements to be marketed without testing, but the added safety evaluation by the FDA will reduce the risk of disastrous outcomes that have plagued many approaches to weight control. Support for a place for orlistat as an OTC product includes the inadequacy of current programs, empowerment of the public, lower cost, and bringing pharmacists into weight-control programs. The downside includes improper use of OTC orlistat that may not result in achieving individual expectations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239604     DOI: 10.1038/oby.2007.100

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

Review 1.  Successful aging: Advancing the science of physical independence in older adults.

Authors:  Stephen D Anton; Adam J Woods; Tetso Ashizawa; Diana Barb; Thomas W Buford; Christy S Carter; David J Clark; Ronald A Cohen; Duane B Corbett; Yenisel Cruz-Almeida; Vonetta Dotson; Natalie Ebner; Philip A Efron; Roger B Fillingim; Thomas C Foster; David M Gundermann; Anna-Maria Joseph; Christy Karabetian; Christiaan Leeuwenburgh; Todd M Manini; Michael Marsiske; Robert T Mankowski; Heather L Mutchie; Michael G Perri; Sanjay Ranka; Parisa Rashidi; Bhanuprasad Sandesara; Philip J Scarpace; Kimberly T Sibille; Laurence M Solberg; Shinichi Someya; Connie Uphold; Stephanie Wohlgemuth; Samuel Shangwu Wu; Marco Pahor
Journal:  Ageing Res Rev       Date:  2015-10-14       Impact factor: 10.895

Review 2.  Current management and recommendations for access to antiviral therapy of herpes labialis.

Authors:  Anthony Cunningham; Paul Griffiths; Peter Leone; Adrian Mindel; Rajul Patel; Lawrence Stanberry; Richard Whitley
Journal:  J Clin Virol       Date:  2011-09-01       Impact factor: 3.168

3.  Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health.

Authors:  Annabella Vitalone; Francesca Menniti-Ippolito; Paola Angela Moro; Fabio Firenzuoli; Roberto Raschetti; Gabriela Mazzanti
Journal:  Eur J Clin Pharmacol       Date:  2011-01-18       Impact factor: 2.953

Review 4.  Acute liver injury following Garcinia cambogia weight-loss supplementation: case series and literature review.

Authors:  Giada Crescioli; Niccolò Lombardi; Alessandra Bettiol; Ettore Marconi; Filippo Risaliti; Michele Bertoni; Francesca Menniti Ippolito; Valentina Maggini; Eugenia Gallo; Fabio Firenzuoli; Alfredo Vannacci
Journal:  Intern Emerg Med       Date:  2018-05-25       Impact factor: 3.397

5.  Investigations of botanicals on food intake, satiety, weight loss and oxidative stress: study protocol of a double-blind, placebo-controlled, crossover study.

Authors:  Stephen D Anton; Jonathan Shuster; Christiaan Leeuwenburgh
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2011-11

6.  Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study.

Authors:  R S Padwal; S Damjanovic; K M Schulze; R Z Lewanczuk; D C W Lau; A M Sharma
Journal:  J Obes       Date:  2010-11-21

Review 7.  The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA.

Authors:  Charles Baum; Katherine Andino; Eric Wittbrodt; Shelley Stewart; Keith Szymanski; Robin Turpin
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

8.  Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Authors:  Young-Gyu Cho; Ji-Hye Jung; Jae-Heon Kang; Jin Soo Kwon; Seung Pil Yu; Tae Gon Baik
Journal:  BMC Complement Altern Med       Date:  2017-07-28       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.